Literature DB >> 9593694

State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate.

M Jabůrek1, V Yarov-Yarovoy, P Paucek, K D Garlid.   

Abstract

The mitochondrial KATP channel (mitoKATP) is hypothesized to be the receptor for the cardioprotective effects of K+ channel openers (KCO) and for the blocking of cardioprotection by glyburide and 5-hydroxydecanoate (5-HD). Studies on glyburide have indicated that this drug is inactive in isolated mitochondria. No studies of the effects of 5-HD on isolated mitochondria have been reported. This paper examines the effects of glyburide and 5-HD on K+ flux in isolated, respiring mitochondria. We show that mitoKATP is completely insensitive to glyburide and 5-HD under the experimental conditions in which the open state of the channel is induced by the absence of ATP and Mg2+. On the other hand, mitoKATP became highly sensitive to glyburide and 5-HD when the open state was induced by Mg2+, ATP, and a physiological opener, such as GTP, or a pharmacological opener, such as diazoxide. In these open states, glyburide (K1/2 values 1-6 microM) and 5-HD (K1/2 values 45-75 microM) inhibited specific, mitoKATP-mediated K+ flux in both heart and liver mitochondria from rat. These results are consistent with a role for mitoKATP in cardioprotection and show that different open states of mitoKATP, although catalyzing identical K+ fluxes, exhibit very different susceptibilities to channel inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593694

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  Pathophysiological and protective roles of mitochondrial ion channels.

Authors:  B O'Rourke
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

Review 2.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 3.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 4.  Physiology of potassium channels in the inner membrane of mitochondria.

Authors:  Ildikò Szabò; Luigi Leanza; Erich Gulbins; Mario Zoratti
Journal:  Pflugers Arch       Date:  2011-11-18       Impact factor: 3.657

5.  Functioning of the mitochondrial ATP-dependent potassium channel in rats varying in their resistance to hypoxia. Involvement of the channel in the process of animal's adaptation to hypoxia.

Authors:  Galina D Mironova; Maria I Shigaeva; Elena N Gritsenko; Svetlana V Murzaeva; Olga S Gorbacheva; Elena L Germanova; Ludmila D Lukyanova
Journal:  J Bioenerg Biomembr       Date:  2010-11-17       Impact factor: 2.945

Review 6.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

7.  Mitochondrial ATP-sensitive potassium channel activity and hypoxic preconditioning are independent of an inwardly rectifying potassium channel subunit in Caenorhabditis elegans.

Authors:  Andrew P Wojtovich; Peter DiStefano; Teresa Sherman; Paul S Brookes; Keith Nehrke
Journal:  FEBS Lett       Date:  2012-01-21       Impact factor: 4.124

Review 8.  Mitochondrial ion channels: gatekeepers of life and death.

Authors:  Brian O'Rourke; Sonia Cortassa; Miguel A Aon
Journal:  Physiology (Bethesda)       Date:  2005-10

9.  Modulation of a plant mitochondrial K+ATP channel and its involvement in cytochrome c release.

Authors:  Elisa Chiandussi; Elisa Petrussa; Francesco Macrì; Angelo Vianello
Journal:  J Bioenerg Biomembr       Date:  2002-06       Impact factor: 2.945

10.  Quinine inhibits mitochondrial ATP-regulated potassium channel from bovine heart.

Authors:  P Bednarczyk; A Kicińska; V Kominkova; K Ondrias; K Dolowy; A Szewczyk
Journal:  J Membr Biol       Date:  2004-05-15       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.